Abbas M, Shanmugam I, Bsaili M, Hromas R, Shaheen M (2014) The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination. J Biol Chem 289:14009–14019
Article CAS PubMed PubMed Central Google Scholar
Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, Dominguez Escrig JL et al (2022) European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol 81:75–94
Benjamin AB, Zhou X, Isaac O, Zhao H, Song Y, Chi X et al (2014) PRP19 upregulation inhibits cell proliferation in lung adenocarcinomas by p21-mediated induction of cell cycle arrest. Biomed Pharmacother 68:463–470
Article CAS PubMed Google Scholar
Chanarat S, Strasser K (2013) Splicing and beyond: the many faces of the Prp19 complex. Biochim Biophys Acta 1833:2126–2134
Article CAS PubMed Google Scholar
Dariane C, Timsit MO (2022) DNA-damage-repair gene alterations in genitourinary malignancies. Eur Surg Res 63:155–164
Article CAS PubMed Google Scholar
de Moura TR, Mozaffari-Jovin S, Szabo CZK, Schmitzova J, Dybkov O, Cretu C et al (2018) Prp19/Pso4 is an autoinhibited ubiquitin ligase activated by stepwise assembly of three splicing factors. Mol Cell 69:979–992
Font A, Taron M, Gago JL, Costa C, Sanchez JJ, Carrato C et al (2011) BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer. Ann Oncol 22:139–144
Article CAS PubMed Google Scholar
Gao X, Liu J, Fan D, Li X, Fang Z, Yan K et al (2022) Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Oncol Rep 47:33
Article CAS PubMed Google Scholar
He Y, Huang C, Cai K, Liu P, Chen X, Xu YI et al (2021) PRPF19 promotes tongue cancer growth and chemoradiotherapy resistance. Acta Biochim Biophys Sin 53:893–902
Article CAS PubMed Google Scholar
Iovine B, Iannella ML, Bevilacqua MA (2011) Damage-specific DNA binding protein 1 (DDB1): a protein with a wide range of functions. Int J Biochem Cell Biol 43:1664–1667
Article CAS PubMed Google Scholar
Khan A, Dellago H, Terlecki-Zaniewicz L, Karbiener M, Weilner S, Hildner F et al (2017) SNEV(hPrp19/hPso4) regulates adipogenesis of human adipose stromal cells. Stem Cell Rep 8:21–29
Li X, Heyer WD (2008) Homologous recombination in DNA repair and DNA damage tolerance. Cell Res 18:99–113
Article CAS PubMed Google Scholar
Lord CJ, Ashworth A (2012) The DNA damage response and cancer therapy. Nature 481:287–294
Article CAS PubMed Google Scholar
Lu JL, Xia QD, Lu YH, Liu Z, Zhou P, Hu HL et al (2020) Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis. Cancer Med 9:7800–7809
Article PubMed PubMed Central Google Scholar
Mahajan K (2016) hPso4/hPrp19: a critical component of DNA repair and DNA damage checkpoint complexes. Oncogene 35:2279–2286
Article CAS PubMed Google Scholar
Mahajan KN, Mitchell BS (2003) Role of human Pso4 in mammalian DNA repair and association with terminal deoxynucleotidyl transferase. Proc Natl Acad Sci USA 100:10746–10751
Article CAS PubMed PubMed Central Google Scholar
Man X, Piao C, Lin X, Kong C, Cui X, Jiang Y (2019) USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. J Exp Clin Cancer Res CR 38:259
Marechal A, Li JM, Ji XY, Wu CS, Yazinski SA, Nguyen HD et al (2014) PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry. Mol Cell 53:235–246
Article CAS PubMed Google Scholar
Mehlich D, Lomiak M, Sobiborowicz A, Mazan A, Dymerska D, Szewczyk LM et al (2021) MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance. Cell Death Dis 12:1111
Article CAS PubMed PubMed Central Google Scholar
Meng Y, Qiu L, Zeng X, Hu X, Zhang Y, Wan X et al (2022) Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy. Signal Transduct Target Ther 7:388
Article CAS PubMed PubMed Central Google Scholar
Messing EM, Tangen CM, Lerner SP, Sahasrabudhe DM, Koppie TM, Wood DP Jr et al (2018) Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non-muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial. JAMA 319:1880–1888
Article CAS PubMed PubMed Central Google Scholar
Mullane SA, Werner L, Guancial EA, Lis RT, Stack EC, Loda M et al (2016) Expression levels of DNA damage repair proteins are associated with overall survival in platinum-treated advanced urothelial carcinoma. Clin Genitourin Cancer 14:352–359
Mun JY, Baek SW, Park WY, Kim WT, Kim SK, Roh YG et al (2020) E2F1 promotes progression of bladder cancer by modulating RAD54L involved in homologous recombination repair. Int J Mol Sci. https://doi.org/10.3390/ijms21239025
Article PubMed PubMed Central Google Scholar
Ohi MD, Vander Kooi CW, Rosenberg JA, Ren L, Hirsch JP, Chazin WJ et al (2005) Structural and functional analysis of essential pre-mRNA splicing factor Prp19p. Mol Cell Biol 25:451–460
Article CAS PubMed PubMed Central Google Scholar
Prasanna T, Craft P, Balasingam G, Haxhimolla H, Pranavan G (2017) Intravesical gemcitabine versus intravesical Bacillus Calmette-Guerin for the treatment of non-muscle invasive bladder cancer: an evaluation of efficacy and toxicity. Front Oncol 7:260
Article PubMed PubMed Central Google Scholar
Qiu D, Hu J, Hu J, Yu A, Othmane B, He T et al (2021) PMEPA1 is a prognostic biomarker that correlates with cell malignancy and the tumor Microenvironment in bladder cancer. Front Immunol 12:705086
Article CAS PubMed PubMed Central Google Scholar
Sharma A, Singh K, Almasan A (2012) Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol 920:613–626
Article CAS PubMed Google Scholar
Sun S, Jiang K, Zeng J (2022) Differential expression of DNA damage repair genes after chemoradiotherapy and inhibition rate in different bladder cancer cells. Transl Androl Urol 11:1336–1344
Article PubMed PubMed Central Google Scholar
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71:209–249
Teoh JY, Huang J, Ko WY, Lok V, Choi P, Ng CF et al (2020) Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol 78:893–906
Wang SC (2014) PCNA: a silent housekeeper or a potential therapeutic target? Trends Pharmacol Sci 35:178–186
Wang JYJ (2019) Cell death response to DNA damage. Yale J Biol Med 92:771–779
CAS PubMed PubMed Central Google Scholar
Wojtuszkiewicz A, Assaraf YG, Maas MJ, Kaspers GJ, Jansen G, Cloos J (2015) Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance. Expert Opin Drug Metab Toxicol 11:673–689
Article CAS PubMed Google Scholar
Xie R, Chen X, Cheng L, Huang M, Zhou Q, Zhang J et al (2021) NONO inhibits lymphatic metastasis of bladder cancer via alternative splicing of SETMAR. Mol Ther J Am Soc Gene Ther 29:291–307
Xiong Y, Ju L, Yuan L, Chen L, Wang G, Xu H et al (2021) KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer. Oncogene 40:1595–1608
Article CAS PubMed Google Scholar
Yano K, Takahashi RU, Shiotani B, Abe J, Shidooka T, Sudo Y et al (2021) PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA. J Biol Chem 297:100882
Article CAS PubMed PubMed Central Google Scholar
Yin J, Zhu JM, Shen XZ (2012) New insights into pre-mRNA processing factor 19: a multi-faceted protein in humans. Biol Cell 104:695–705
Comments (0)